← SynDRA
LEVAMLODIPINE
SynDRA canonical compound SYN0033692 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CACNA1C | CACNA1D | CACNA1F | CACNA1S |
|---|
| Mechanism of action | calcium channel blocker |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
- CACNA1C
- CACNA1D
- CACNA1F
- CACNA1S
Mechanisms of action (all sources)
- CACNA1C BLOCKER
- Voltage-gated L-type calcium channel blocker
- CACNA1S BLOCKER
- CACNA1D BLOCKER
- CACNA1F BLOCKER
- calcium channel blocker
ATC classes
- C08C · SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
Cross-references
Synonyms
- levamlodipine malate
- levamlodipine besylate
- (S)-amlodipine
- levoamlodipine
- l-Amlodipine
- Levamlodipino
- Amlodipine, (s)-
- S-amlodipine
- Levamlodipine component of agsav301
- Levamlodipine (hypertension)
- S-amlodipine gentisate
- Levamlodipine (hypertension), SK Chemicals
- S-amlodipine (hypertension), SK Chemicals
- 0P6NLP6806
- AGSAV301 COMPONENT LEVAMLODIPINE
- S-Amlodipine
- levamlodipino
- (-)-Amlodipine
- levamlodipinum
- RefChem:56702
- DTXCID201333652
- (S)-Amlodipine
- Levamlodipine [INN]
- MFCD09832686
- Levoamlodipine
- Amlodipine (S)-Isomer
- C20H25ClN2O5
- UNII-0P6NLP6806
- SCHEMBL41283
- LEVAMLODIPINE [WHO-DD]
- orb1308241
- SCHEMBL30994756
- CHEBI:53796
- HTIQEAQVCYTUBX-KRWDZBQOSA-N
- GLXC-10863
- HMS3885M19
- EBC-26983
- s3674
Reported adverse events
- Dizziness
- Fatigue
- Flushing
- Nausea
- Palpitations
- Somnolence
Look up LEVAMLODIPINE in the interactive SynDRA portal →